亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

濟南偉都化工醫藥有限公司  

主要致力于各種化工醫藥原料及中間體的生產研發及銷售,包括抗消炎鎮痛類,吡啶硼酸類,吡啶衍生物,苯硼酸,嘧啶類,碘吡啶類,以及吲哚類。

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:孟清
  • 電話:86-531-88681812
  • 郵件:wedochem01@126.com
  • 傳真:86-531-88873470
  • QQ:1666542939
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 氯甲酰乙酸乙酯 36239-09-5
氯甲酰乙酸乙酯 36239-09-5
單價 面議對比
詢價 暫無
發貨 山東濟南市付款后3天內
型號 36239-09-5
規格 氯甲酰乙酸乙酯 36239-09-5
過期 長期有效
更新 2013-11-20 11:48
 
詳細信息

氯甲酰乙酸乙酯 36239-09-5

CAS 號  36239-09-5
產品英文名稱    Ethyl malonyl chloride
產品英文別名    Acetic acid, (chloroformyl)-, ethyl ester; (Chlorocarbonyl)acetic acid ethyl ester; 2-(Ethoxycarbonyl)acetyl chloride; 3-Chloro-3-oxopropanoic acid ethyl ester; Carbethoxyacetyl chloride; Carbethoxyethanoyl chloride; Carboethoxyacetyl chloride; Ethoxymalonyl chloride; Ethyl (chlorocarbonyl)acetate; Ethyl (chloroformyl)acetate; Ethyl 3-chloro-3-oxopropanoate; Ethyl 3-chloro-3-oxopropionate; Ethyl 3-oxo-3-chloropropanoate; Ethyl malonoyl chloride; Ethyl malonyl chloride; Malonic ethyl ester chloride; Monoethyl malonyl chloride
產品中文名稱    氯甲酰乙酸乙酯
結構圖     
分子式    C5H7ClO3
分子量    150.56

95%以上 淡黃色液體

©2025 濟南偉都化工醫藥有限公司 版權所有   技術支持:化工網   訪問量:38720  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |